A million dollars sounds like enough to retire on. Whether it actually is depends entirely on what you make it do. At a blended yield of roughly 6%, $1,000,000 produces exactly $60,000 per year in investment income. Four tickers currently sitting in that yield range are Pfizer Inc (NYSE:PFE | PFE Price Prediction), Altria Group (NYSE:MO), Verizon Communications Inc (NYSE:VZ), and Enterprise Products Partners LP (NYSE:EPD). Each carries distinct risks and illustrates what it costs to buy $60,000 a year at different points on the yield spectrum.
Capital Required Across Three Yield Tiers
The math is simple: income target divided by yield equals capital required. At 3.5%, you need approximately $1,714,000 to generate $60,000 annually. At 6%, you need exactly $1,000,000. At 10%, you need $600,000.
Conservative tier (3% to 4% yield). Broad dividend growth funds and blue-chip equities live here. You need the most capital, but the portfolio is diversified, dividends typically grow over time, and principal is most likely to appreciate. The 10-year Treasury currently yields around 4.3%, which means a conservative dividend growth portfolio offers only a modest income premium over risk-free government bonds. The case is long-term compounding, not current income maximization.
Moderate tier (5% to 7% yield). This is where PFE, MO, VZ, and EPD cluster. At 6%, the equation yields exactly $1,000,000 in required capital. The four tickers each carry yields in the 6% to 7% range: Pfizer at approximately 6.3%, Altria at approximately 6.2%, Verizon at approximately 5.7%, and Enterprise Products Partners at approximately 5.7%. A portfolio weighted toward higher-yielding names closes the gap to a blended 6%. The capital requirement drops roughly $700,000 compared to the conservative tier, a meaningful difference for those below the $1.7 million threshold.
Aggressive tier (8% to 14% yield). Leveraged covered call funds, mortgage REITs, and business development companies populate this range. At 10%, you need $600,000. The capital requirement is lowest, but principal erosion is common, distributions can be cut without warning, and the portfolio may shrink in value even while generating income. This tier works best as a supplement to a larger portfolio, not as a standalone income engine.
Four Tickers, Four Risk Profiles: Pharma, Tobacco, Telecom, and Pipelines
Pfizer’s yield is elevated partly because the stock has spent years under pressure from a post-COVID revenue hangover. The company posted a GAAP net loss of $1.65 billion in Q4 2025 due to non-cash impairment charges, but full-year 2025 net income came in at $7.8 billion and the dividend is covered on an adjusted basis. The company has guided for 2026 adjusted EPS of $2.80 to $3.00 and revenue of $59.5 to $62.5 billion. The quarterly dividend has held at $0.43 per share and has been paid without interruption for over 25 years. The risk is a patent cliff, with $1.5 billion in loss-of-exclusivity impact expected in 2026.
Altria’s domestic cigarette volume declined 10% in full-year 2025, yet raised its quarterly dividend to $1.06 per share, its 60th dividend increase in 56 years. The company returned $8 billion to shareholders in 2025 and guided for 2026 adjusted EPS of $5.56 to $5.72. The dividend has grown from $0.44 per quarter in 1999 to $1.06 per quarter today. Volume decline is the structural headwind; pricing power and oral nicotine growth are the offsets.
Verizon carries $144 billion in total debt, which makes income investors pause. What keeps the dividend credible is free cash flow: the company generated $19.8 billion in free cash flow in 2024, well above its dividend obligations. The most recent quarterly payment was $0.69 per share, and the company has delivered 18 consecutive quarters of wireless service revenue growth.
Enterprise Products Partners is a midstream energy master limited partnership that moves natural gas, crude oil, and petrochemicals through pipelines and charges fees. That fee-based model insulates distributions from commodity price swings. EPD has grown its distribution for 27 consecutive years, with the most recent quarterly distribution at $0.55 per unit. Note: MLP ownership generates a K-1 tax form, adding complexity at filing time.
The Growth Advantage Hidden in Lower Yields
A 3.5% yield that grows 8% annually doubles the income stream in roughly nine years. A 10% yield with no growth stays flat or declines if principal erodes. At $60,000 per year, that difference is the gap between an income stream that keeps pace with inflation and one that quietly loses purchasing power.
Altria’s dividend history illustrates this. The quarterly payment was $0.44 in Q1 1999. It is $1.06 today. An investor who bought in 1999 at a modest yield is now collecting a much higher effective yield on their original cost. That is the compounding argument for dividend growth.
The moderate tier is a reasonable middle ground: enough current income to replace a salary without the principal erosion risk of the aggressive tier, and without requiring the $1.7 million capital base of the conservative tier.
Three Steps Before Building This Portfolio
- Calculate your actual annual spending. Many people need to replace less than $60,000 after taxes, mortgage payoff, and reduced work-related expenses. A lower income target drops the capital requirement at every yield tier.
- Model the tax treatment separately. Qualified dividends from Pfizer and Altria are taxed differently than Verizon’s ordinary dividends and Enterprise Products Partners’ K-1 distributions, which may include return of capital. The after-tax income number is what actually hits your account.
- Compare the 10-year total return of a moderate-yield portfolio against a conservative dividend growth portfolio. The current 10-year Treasury at roughly 4.3% means you are giving up only about 175 basis points of risk-free income to own a conservative dividend growth fund. Whether the added complexity and sector risk of the moderate tier is worth it depends on your time horizon and how much principal growth matters to you.